Dr. Mikhail Blagosklonny’s Amazing Contributions to Cancer Treatment

Dr. Mikhail Blagosklonny is an oncologist by profession. Currently, he is an oncology professor at New York’s Buffalo’s Rosewell Park Cancer Institute. In addition to him lecturing at the institution and running his online OncoTarget publication, Dr. Mikhail Blagosklonny is also involved in a lot of research where he helps in making tremendous contribution towards cancer therapy and treatment. Dr. Mikhail Blagosklonny’s goal is to help increase the lifespan of individuals through therapy and also sharing his knowledge. According to a recent online article, Dr. Mikhail Blagosklonny shares the amazing benefits of Rapamycin. Unknown to many people, Rapamycin is a drug administered to patients before undergoing organ transplants to help counter the rejection. This drug was first discovered in 1972 and was always used as a great anti-fungal agent. However, through numerous research, the drug was found to have antiproliferative and immunosuppressive properties. It is as a result of this that the use of the drug as an anti-fungal agent was abandoned. The following are some of the benefits and reasons why Rapamycin is by far the best drug we have according to Dr. Mikhail Blagosklonny.


Immunosuppressant properties:


One of the key uses that Rapamycin is known for is its immunosuppressing effects. Organ plants are foreign agents in the body, and with the body’s immune system in place, naturally, the body’s defense will be forced to fight them which may result in eventualities of the organ transplant failing. By introducing Rapamycin in the body, this drug can suppress the body defense system hence making it safe for the transplant. In addition to this, Mikhail Blagosklonny notes that unlike other immunosuppressant drugs, Rapamycin has no adverse toxic effects on the kidneys and hence its use over time will not in any point cause harm to the body.


Rapamycin is important in the treatment of Cancer


Cancer is one of the complex diseases that continue to bring headaches to patients and their families as well. However, according to Dr. Mikhail Blagosklonny, there is hope at the end of the tunnel. Mikhail notes that Rapamycin, when taken in its right capacities, has the ability to boost the body’s immune system towards cancer tumors. On the other end, it also promotes the regression of the tumors. Thanks to this, Rapamycin can reduce the risks in patients more so those undergoing organ transplants.


What next for Dr. Mikhail Blagosklonny?


As stated earlier, Dr. Mikhail Blagosklonny is a man who wears many hats; however, his efforts are always centralized in making the life of patients better and safer. Thanks to Blagosklonny’s editorial role in his OncorTarget publication, the medical future looks bright. OncorTarget started as a publication that focuses entirely on the discipline of oncoloy, but with the warm and positive feedback of the publication, Dr. Mikhail Blagosklonny was able to expand it to accommodate other disciplines.Thanks to this progress, scientific knowledge and data are now readily available and at no costs. This has helped better the medical field since there is enough knowledge to help individuals take charge of their health.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>